 DURHAM, N.C., Aug. 05, 2022 GLOBE NEWSWIRE -- Humacyte, Inc. Nasdaq: HUMA, a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, will release its financial results for the second quarter ended June 30, 2022, on Friday, August 12, 2022. Management will host a webcast and conference call at 8:00 a.m. ET to provide a corporate and financial update. 